We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$2.83B
AUM Growth
-$51.8M
Cap. Flow
-$96.1M
Cap. Flow %
-3.4%
Top 10 Hldgs %
16%
Holding
1,400
New
374
Increased
259
Reduced
316
Closed
442

Sector Composition

Rank Sector Weight
1 Healthcare 19.64%
2 Financials 15.46%
3 Consumer Discretionary 11.37%
4 Technology 10.29%
5 Energy 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHC icon
501
Encompass Health
EHC
$11B
$811K 0.03%
16,090
+1,760
+12% +$85.4K
SRE icon
502
Sempra
SRE
$57.9B
$811K 0.03%
11,800
-200
-2% -$13.1K
MED icon
503
Medifast
MED
$109M
$808K 0.03%
+6,300
New +$875K
XRAY icon
504
Dentsply Sirona
XRAY
$2.68B
$805K 0.03%
+13,800
New +$741K
NGM
505
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$805K 0.03%
+55,000
New +$805K
FBC
506
DELISTED
Flagstar Bancorp, Inc. New
FBC
$805K 0.03%
+24,300
New +$809K
AIR icon
507
AAR Corp
AIR
$5.59B
$802K 0.03%
21,799
-30,001
-58% -$992K
RETA
508
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$792K 0.03%
+8,400
New +$725K
MNK
509
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$792K 0.03%
+86,300
New +$1.25M
CDK
510
DELISTED
CDK Global, Inc.
CDK
$784K 0.03%
15,861
-9,843
-38% -$527K
XRX icon
511
Xerox
XRX
$386M
$782K 0.03%
22,074
-13,457
-38% -$449K
ZAYO
512
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$777K 0.03%
+23,600
New +$753K
ORLY icon
513
O'Reilly Automotive
ORLY
$72.9B
$776K 0.03%
31,500
+4,305
+16% +$109K
UFS
514
DELISTED
DOMTAR CORPORATION (New)
UFS
$775K 0.03%
17,400
+4,580
+36% +$209K
GHDX
515
DELISTED
Genomic Health, Inc.
GHDX
$768K 0.03%
13,200
+500
+4% +$29.6K
JBLU icon
516
JetBlue
JBLU
$2.28B
$767K 0.03%
+41,474
New +$742K
TGT icon
517
Target
TGT
$65.6B
$765K 0.03%
8,832
-377,968
-98% -$30.5M
JEF icon
518
Jefferies Financial Group
JEF
$12.6B
$764K 0.03%
44,397
-81,042
-65% -$1.39M
LLY icon
519
Eli Lilly
LLY
$1.02T
$764K 0.03%
6,900
-7,571
-52% -$892K
SNBR
520
DELISTED
Sleep Number
SNBR
$764K 0.03%
+18,900
New +$730K
ROST icon
521
Ross Stores
ROST
$80.5B
$762K 0.03%
+7,692
New +$750K
GHC icon
522
Graham Holdings Company
GHC
$5.18B
$759K 0.03%
1,100
-100
-8% -$69.8K
CLB icon
523
Core Laboratories
CLB
$490M
$758K 0.03%
+14,500
New +$850K
HWM icon
524
Howmet Aerospace
HWM
$113B
$756K 0.03%
38,158
+5,297
+16% +$89.4K
CDW icon
525
CDW
CDW
$18.9B
$755K 0.03%
6,804
-11,408
-63% -$1.2M

Similar funds

Schonfeld Strategic Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Schonfeld Strategic Advisors held 1,400 positions worth $2.83B, down 1.8% from $2.88B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Schonfeld Strategic Advisors withdrew a net $96.1M in Q2 2019, closing 442 positions and reducing 316 holdings. Its most notable exit was Conagra Brands, an estimated $43.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Schonfeld Strategic Advisors opened a new position in Equitrans Midstream Corporation Common Stock worth $42.1M.

  • Schonfeld Strategic Advisors's largest Q2 2019 buy was Equitrans Midstream Corporation Common Stock: 2,136,064 shares worth $42.1M.
  • Schonfeld Strategic Advisors added most to NRG Energy in Q2 2019, an estimated $61.4M increase.
  • Schonfeld Strategic Advisors's biggest Q2 2019 reduction was Target, cutting an estimated $30.5M.
  • Schonfeld Strategic Advisors fully exited Conagra Brands in Q2 2019, selling an estimated $43.5M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 16% of its $2.83B portfolio in Q2 2019.
  • Schonfeld Strategic Advisors opened 374 new positions and closed 442 in Q2 2019.
  • Schonfeld Strategic Advisors's portfolio value fell 1.8% quarter-over-quarter to $2.83B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.